Using plant compounds to fix disrupted daily gut microbe chemical rhythms as a new way to fight metabolic disease

Peripheral circadian clocks within intestinal epithelial cells (enterocytes, colonocytes), specialized secretory cells (Paneth cells, goblet cells), and associated immune cells (e.g., dendritic cells, macrophages) directly regulate the local luminal and mucosal environment. The molecular clockwork within these cells controls the rhythmic expression of proteins critical for gut structure, function, and defense. A prime example is the clock-controlled production of antimicrobial peptides (AMPs), such as regenerating islet-derived protein 3γ (Reg3γ) and α-defensins, by Paneth cells in the small intestine. These AMPs are secreted into the gut lumen in a diurnal pattern, creating a temporal landscape of antimicrobial pressure that profoundly shapes microbial community structure by selectively inhibiting or eliminating certain bacterial taxa while allowing others to flourish during specific windows (;). Furthermore, the integrity of the intestinal epithelial barrier, maintained by dynamic protein complexes like tight junctions (e.g., occludin, claudins) and adherens junctions, also exhibits circadian regulation. The rhythmic expression and phosphorylation of these junctional proteins dictate the paracellular permeability of the gut lining, which in turn affects the degree of microbial-associated molecular pattern translocation and the nature of host-microbe interaction at the mucosal surface (). As demonstrated in intestinal epithelium-specificknockout mice, disruption of these local intestinal clocks led to a loss of microbial diurnal fluctuations and compositional dysbiosis even under strictly controlled feeding conditions. This provided definitive evidence for a direct, feeding-independent circadian influence on the microbiome orchestrated from within the gut tissue itself (). [Niu et al., 2024] [Mukherji et al., 2013] [Fujisaka et al., 2018] [Liang et al., 2015] Bmal1

While local clocks play a fundamental role, the most potent external signal for entraining microbial rhythms is the host's behavioral cycle of feeding and fasting (). Time-restricted feeding (TRF), which consolidates all caloric intake to a consistent 8–12 h window aligned with the active phase, has been shown to be a powerful driver and restorer of microbial oscillations (). Notably, TRF can rescue microbial rhythmicity and improve metabolic parameters even in mice with genetically or surgically ablated central (SCN) clocks. It was demonstrated that feeding time itself was a primary, non-photic regulator for the gut microbiome (;). This powerful effect is mediated through two main channels: the rhythmic delivery of dietary substrates (the microbes' primary energy source) and the concomitant fluctuation of host-derived systemic signals that are themselves synchronized to the feeding cycle (). These systemic signals include hormonal fluctuations, body temperature, and bile acid flux. The circadian secretion of glucocorticoids (cortisol in humans, corticosterone in rodents), which peak around the wake-time, has broad immunomodulatory and metabolic effects (). Glucocorticoid receptors are present in some bacteria, and these hormones can influence microbial gene expression and growth dynamics (). Similarly, the rhythmic patterns of appetite-regulating hormones like leptin (satiety signal) and ghrelin (hunger signal) may have direct or indirect effects on microbial physiology, potentially through changes in gut motility or nutrient sensing (). In addition, the robust circadian oscillation in core body temperature (higher during active phase, lower during rest) creates a thermally fluctuating environment within the gut lumen. This daily temperature cycle can selectively influence the growth rates and metabolic activities of different microbial species, as bacterial enzymes have optimal temperature ranges (;). Besides, the liver clock tightly regulates the synthesis of primary BAs via transcriptional control of the rate-limiting enzyme cholesterol 7α-hydroxylase (CYP7A1). This results in a robust diurnal rhythm in the hepatic synthesis and subsequent biliary secretion of primary BAs into the duodenum (). BAs are potent detergents with inherent antimicrobial properties. Their rhythmic flux into the intestine imposes a significant, time-varying chemical and selective pressure on the microbial community, favoring bacteria equipped with bile acid resistance and transformation enzymes over those sensitive to BA detergent action (). [Patterson and Sears, 2017] [Mattson et al., 2014] [Sharon et al., 2016] [Zarrinpar et al., 2014] [Landgraf et al., 2015] [Delezie and Challet, 2011] [Ma et al., 2017] [Paulose et al., 2016] [Qin et al., 2012] [Ríos-Covián et al., 2016] [Govindarajan et al., 2016] [Turnbaugh et al., 2006]

The erosion of structured meal times and the trend of consuming significant calories in the late evening or biological night are now prevalent. These habits delivers nutrient substrates to the gut ecosystem at an aberrant circadian phase—a period normally associated with fasting, sleep, and insulin resistance. This disrupts the coordinated, anticipatory metabolic response of the microbiota. Some rodent studies provided incontrovertible evidence: compared with mice fed with isocaloric high-fat diets during their active (dark) phase, mice consuming the same diet exclusively during their normal resting (light) phase developed significantly greater weight gain, adiposity, glucose intolerance, hyperinsulinemia, and hepatic steatosis (;;). Controlled human intervention studies also mirrored these findings. Late-evening meals or shifting food intake to later hours impaired postprandial glucose tolerance, altered lipid metabolism (e.g., leading to higher postprandial triglycerides). Additionally, it reduced diet-induced thermogenesis compared to eating earlier in the day (). Metagenomic and metabolomic analyses revealed that such mistimed eating not only altered the absolute abundance of key bacterial families (e.g., reducing) but, more importantly, dampened the normal rhythmicity of microbial taxonomic and functional gene profiles involved in carbohydrate and amino acid metabolism (). [Arble et al., 2009] [Bisanz et al., 2019] [Shimizu et al., 2018] [Wehrens et al., 2017] [Zarrinpar et al., 2014] Lachnospiraceae

Shift work and transmeridian travel can immediately disrupt the body's internal timing. This disruption often becomes persistent, causing the master light-sensitive clock to fall out of sync with clocks in metabolic organs. Specifically, the central SCN clock—entrained by light—becomes misaligned with peripheral clocks, which are more strongly set by the altered timing of food intake, sleep, and activity (). Epidemiological data consistently showed that shift workers, particularly those on rotating night shifts, had a 20%−40% increased risk of developing obesity, T2DM, and coronary heart disease, even after adjusting for lifestyle factors (). Experimental models, both in human volunteers under controlled laboratory conditions simulating night-shift work and in mice subjected to weekly phase-advancements mimicking jet lag, demonstrated that circadian misalignment rapidly and reproducibly leads to significant alterations in gut microbiota composition. These changes are typically characterized by a decrease in the relative abundance of beneficial, SCFA-producing bacteria from families such asand, an increase in taxa associated with inflammation (e.g.,), and a profound dampening or complete obliteration of diurnal microbial fluctuations (;). The microbial community loses its temporal structure, becoming static in a dysbiotic state. [Tu et al., 2021] [Wang X. S. et al., 2011] [Voigt et al., 2014] [Kervezee et al., 2020] Lachnospiraceae Ruminococcaceae Coprococcus

Social jet lag is a highly prevalent condition of chronic mismatch. It occurs between an individual's endogenous circadian preference (chronotype, such as “night owl” or “morning lark”) and their socially imposed sleep-wake schedule, like early work or school start times. This mismatch results in recurrent, weekly bouts of circadian misalignment, typically on work or school days (). Even mild social jet lag (a discrepancy of ≥2 h) is associated with adverse metabolic profiles, including higher body mass index (BMI), increased insulin resistance (HOMA-IR), and unfavorable lipid markers (). Emerging evidence links social jet lag to distinct and measurable microbial signatures. These include an overall reduction in microbial alpha-diversity, a key marker of ecosystem health and stability. They also involved an enrichment of bacterial groups associated with inflammatory markers, suggesting this common, chronic CD exerts a selective pressure that reshapes the gut into a less favorable, less rhythmic state. [Wang X. S. et al., 2011] [Roenneberg et al., 2012]

In a healthy, synchronized state, the relative abundances of specific bacterial taxa oscillate predictably over the 24-h period. For instance, members of the, particularly those equipped with enzymes to break down complex dietary fibers, often peak in abundance during or shortly after the host's feeding phase (;). Conversely, mucin-degrading specialists like() might exhibit higher relative abundance during the fasting phase, feeding on host-derived mucosal glycans. CD, whether induced by genetic knockout of central clock genes () or by environmental manipulation like experimental jet lag, dramatically flattens these population oscillations (). As a consequence, the microbial community loses its dynamic ebb and flow, becoming “stuck” in a compositionally and functionally monotonous state that is maladapted to the host's cyclically changing metabolic needs (). Firmicutes phylum Akkermansia muciniphila Verrucomicrobia phylum Bmal1, Per1/2 [Nie et al., 2017] [Oosterman et al., 2015] [Thaiss et al., 2014] [Yang et al., 2022]

In addition to shifts in which species are present, CD also disrupts the rhythmic expression of microbial genes, which is the primary driver of the community's function. Metatranscriptomic analyses (sequencing of microbial community RNA) revealed that under conditions of CD, the normal daily expression patterns of genes responsible for critical bacterial functions were severely blunted or lost (). These include genes encoding carbohydrate-active enzymes (CAZymes) for dietary fiber breakdown, key enzymes in SCFA synthesis pathways (e.g., butyryl-CoA:acetate CoA-transferase for butyrate production), genes for flagellar assembly and bacterial motility, and transporters for nutrients like sugars and amino acids (;). This transcriptional arrhythmia translates directly into a mistimed production of metabolites. Instead of a coordinated, anticipatory pulse of SCFAs or a rhythmic conversion of primary to secondary BAs aligned with host metabolic demands, microbial metabolic output became erratic, constitutively subdued, or inappropriately persistent. The normal signal becomes noise (;). [Yang et al., 2020] [Kumar et al., 2020] [Wang Z. et al., 2011] [Mukhopadhya and Louis, 2025] [Yoo et al., 2004]

The most compelling evidence that a CD-perturbed microbiome directly drives metabolic dysfunction comes from FMT experiments. They showed that a circadian-disrupted microbiome was a direct and sufficient driver of metabolic dysfunction, not just a passive correlate. Thus, FMT studies provided definitive proof of causality (). These studies involved transplanting the gut microbiota from donor mice subjected to chronic jet lag or from circadian clock mutant mice (e.g.,double knockout) into germ-free (axenic) or antibiotic-treated wild-type recipient mice. Remarkably, recipients of the “CD-microbiota” developed significant glucose intolerance, increased adiposity, and other metabolic disturbances, despite being housed under normal, regular light-dark cycles and having no inherent circadian defect themselves (;). This demonstrated conclusively that the dysregulated, arrhythmic microbial community itself is a transmissible pathogenic entity, capable of inducing metabolic disease in a previously healthy host (). It solidified the gut microbiome as a key mediator in the causal pathway from CD to metabolic syndrome (). [Zarrinpar et al., 2016] [Voigt et al., 2014] [Leone et al., 2015] [Zhang et al., 2017] [Zhang et al., 2021] Per1/2

summarizes the key impacts of different CD models on the gut microbiota and the consequent host metabolic phenotypes, providing a concise overview of the experimental evidence discussed in this section. Table 1

Butyrate is like the chrono-metabolic gatekeeper and epithelial guardian. Butyrate is a multi-faceted signaling molecule with profound local and systemic effects (). Locally in the colon, it serves as the preferred energy source for colonocytes (intestinal epithelial cells). Its rhythmic supply regulates the circadian expression of genes involved in epithelial cell proliferation, differentiation, and, crucially, the assembly of tight junction proteins (e.g., occludin, claudins, zonula occludens-1). This maintains the diurnal integrity of the gut barrier (). A disrupted butyrate rhythm deranges the function of this barrier, leading to increased intestinal permeability or “leaky gut.” This allows the translocation of bacterial pro-inflammatory molecules, most notably lipopolysaccharide (LPS) from Gram-negative bacteria, into the portal and then systemic circulation—a condition termed metabolic endotoxemia (). Elevated circulating LPS triggers a chronic low-grade inflammatory state via activation of Toll-like receptor 4 (TLR4) on immune cells, a key driver of systemic insulin resistance and adipose tissue inflammation (). In addition to its local guardianship of the epithelial barrier, butyrate exerts systemic epigenetic influence as a potent inhibitor of histone deacetylases (HDACs). Rhythmic HDAC inhibition in peripheral tissues like the liver is an important epigenetic mechanism contributing to the circadian expression of metabolic genes. For example, butyrate's rhythmic levels help fine-tune the liver's daily production of glucose. Its daily ebb and flow helps set the pace for the expression of phosphoenolpyruvate carboxykinase (PCK1), a rate-limiting enzyme in hepatic gluconeogenesis (). Loss of this timing signal can lead to inappropriately timed or excessive hepatic glucose output during periods when it should be suppressed (e.g., the fed state), directly contributing to fasting and postprandial hyperglycemia (;). Butyrate also activates G-protein coupled receptors (GPCRs) like GPR109a on immune cells, promoting anti-inflammatory interleukin-10 (IL-10) production, and may entrain peripheral clocks, further linking microbial metabolism to host circadian physiology (). [Zietak et al., 2016] [Fujisaka et al., 2018] [Steliou et al., 2012] [Cani, 2018] [Zubcevic et al., 2019] [Kasukawa et al., 2012] [Santisteban et al., 2017] [Tahara et al., 2018]

Propionate is largely cleared by the liver via first-pass metabolism, where it can serve as a substrate for gluconeogenesis. In the intestinal lumen, propionate activates GPCRs GPR41 and GPR43 on enteroendocrine L-cells. This GPR activation stimulates the rhythmic release of the anorexigenic (satiety) hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1). PYY slows gastric emptying and intestinal transit (the “ileal brake”), while GLP-1 potentiates glucose-dependent insulin secretion, inhibits glucagon release, and promotes satiety in the brain (). Arrhythmic propionate production may blunt this crucial postprandial satiety and insulinotropic signal, potentially contributing to overeating and impaired glycemic control. Acetate, the most abundant SCFA in circulation, can reach the peripheral tissues. In the liver, it can serve as a substrate forlipogenesis (DNL), the process of converting carbohydrates to fatty acids (). When the availability of acetate is mistimed—for example, peaking during a circadian phase associated with insulin resistance (as occurred in night-eating)—it may contribute to hepatic lipid accumulation and dyslipidemia (). In addition, acetate can cross the blood-brain barrier, influence central appetite regulation and may have effects on hypothalamic function (). [Chambers et al., 2015] [Han et al., 2021] [Perry et al., 2016] [Alenghat, 2015] de novo

Hepatic expression of, the gene encoding the rate-limiting enzyme in the classical pathway of bile acid synthesis, is under strong circadian control, typically peaking during the active phase (). This drives a rhythm in the secretion of primary BAs (cholic acid, chenodeoxycholic acid) into the bile. Upon reaching the distal ileum and colon, a subset of gut bacteria, notably within the Clostridium cluster (e.g.,), perform a critical biotransformation: 7α-dehydroxylation, converting primary BAs into secondary BAs like deoxycholic acid (DCA) and lithocholic acid (LCA) (). CD alters both the host's synthetic rhythm (via clock disruption) and the abundance/activity of these specialized transforming bacteria, resulting in an aberrant bile acid pool. This pool is characterized by an altered ratio of primary to secondary BAs, a shift in hydrophobicity, and a loss of the normal daily variation in composition and concentration (). The side effect is an arrhythmic delivery of BAs signals to intestinal and systemic receptors (). Cyp7a1 Clostridium scindens [Govindarajan et al., 2016] [Sayin et al., 2013] [Kuipers et al., 2014] [Beli et al., 2018]

BAs are endogenous ligands for two key signaling receptors: the farnesoid X receptor (FXR), a nuclear receptor, and Takeda G protein-coupled receptor 5 (TGR5/GPBAR1). Their rhythmic activation is essential for metabolic coordination (). [Bishehsari et al., 2015]

FXR Signaling: in the ileal enterocyte, rhythmic activation of FXR by BAs induces the expression and secretion of fibroblast growth factor 19 (FGF19; FGF15 in mice). FGF19 travels via portal blood to the liver, where it binds its receptor (FGFR4/β-KLOTHO complex) to suppress CYP7A1 expression, completing a negative feedback loop that rhythmically controls BAs synthesis. FGF19 also regulates hepatic glycogen and protein synthesis. In the liver itself, FXR activation regulates the expression of genes involved in gluconeogenesis (suppressingand), lipogenesis (inhibiting SREBP-1c), and VLDL-triglyceride secretion (;). Pck1 G6pc [Kuipers et al., 2014] [Wahlström et al., 2016]

TGR5 Signaling: activation of TGR5 on intestinal L-cells stimulates GLP-1 secretion, enhancing insulin secretion and promoting satiety. In brown adipose tissue and skeletal muscle, TGR5 activation increases energy expenditure and thermogenesis via a cyclic AMP (cAMP)-dependent mechanism that upregulates type 2 iodothyronine deiodinase (DIO2), converting thyroxine (T4) to active triiodothyronine (T3) (;). [Canfora et al., 2015] [Donohoe et al., 2011]

CD leads to arrhythmic tissue exposure to BAs. This results in the uncoordinated, suboptimal, or constitutive activation of FXR and TGR5 receptors. Such dysregulation disrupts the normal phasing of metabolic processes. For instance, postprandial suppression of hepatic glucose production may fail, lipogenesis may stay chronically high, the BAs feedback may become dysregulated (increasing cholestatic risk), and thermogenesis may be blunted. Collectively, these disturbances promote hyperglycemia, dyslipidemia, and weight gain—the hallmarks of metabolic disease.

Dietary tryptophan is metabolized through several competing pathways between host and microbe. Gut bacteria convert tryptophan into a variety of indole and derivative compounds, many of which are potent ligands for the aryl hydrocarbon receptor (AhR), such as indole, indole-3-aldehyde, indole-3-acetic acid, and indole-3-propionic acid (IPA) (). The activation of AhR in intestinal immune cells (e.g., innate lymphoid cells type 3, ILC3s) and epithelial cells is crucial for maintaining mucosal immune homeostasis, barrier function, and the production of the cytokine interleukin-22 (IL-22). IL-22, in turn, stimulates Paneth and goblet cells to produce antimicrobial peptides and mucins, reinforcing the barrier (). Microbial tryptophan metabolism also exhibits diurnal patterns tied to nutrient availability. Its disruption under CD may lead to a deficit in these beneficial AhR ligands, weakening the gut barrier, compromising mucosal immunity, and exacerbating local and systemic inflammation (). Furthermore, the host's synthesis of the neurotransmitter serotonin, which regulates gut motility, mood, and platelet function, depends on the availability of its precursor, tryptophan. The microbiome competes for and metabolizes tryptophan, thereby influencing the host's serotonergic system. Disruption of this balance may link gut dysbiosis to neurobehavioral comorbidities which were commonly found in metabolic disease, such as depression and anxiety (). [Cheng et al., 2020] [Natividad et al., 2018] [Cho et al., 2019] [Yano et al., 2015]

While TMAO levels in plasma may not exhibit a strong endogenous circadian rhythm in humans, the microbial production of its precursor, trimethylamine (TMA), is directly influenced by the availability of substrate from the diet (). TMA is generated by specific gut bacterial enzymes (e.g., CutC/D, CntA/B) from dietary nutrients abundant in red meat, eggs, and certain fish, namely, choline, L-carnitine, and phosphatidylcholine. CD, by altering feeding patterns and microbial community structure, may promote an environment enriched in TMA-producing bacteria (e.g., somespecies) (;). Elevated TMAO levels are a strong, independent risk factor for atherosclerosis, thrombosis, and major adverse cardiovascular events (). TMAO promotes these effects by enhancing macrophage foam cell formation, stimulating platelet hyperreactivity, and promoting vascular inflammation (). Thus, CD can exacerbate a microbial metabolic pathway that directly links diet to cardiovascular complications, a leading cause of mortality in metabolic syndrome (). [Cresci and Bawden, 2015] [Koeth et al., 2013] [Sanchez-Rodriguez et al., 2020] [Cuevas-Sierra et al., 2019] [Zhu et al., 2016] [Daniel et al., 2021] Enterobacteriaceae, Prevotella

provides a summary of the key microbial metabolites discussed, their rhythmic functions, and the consequences of their dysregulation due to CD, integrating insights from the references cited throughout this section. Table 2

This vast and diverse class of compounds (flavonoids, stilbenes, phenolic acids, lignans) is often poorly absorbed in the upper gastrointestinal tract. As a result, a significant fraction reaches the colon intact, where they exert potent prebiotic effects and serve as substrates for microbial transformation (). Different polyphenol structures exhibit distinct selectivity for microbial groups. For example, resveratrol (a stilbene from grapes, blueberries, peanuts) has been consistently shown in rodent models of diet-induced obesity to increase the abundance of. This mucin-degrading bacterium is strongly associated with improved gut barrier function. It also links to reduced metabolic endotoxemia and enhanced metabolic health. In addition, resveratrol also promotes the genarate ofandspecies (;). Anthocyanins (pigments in berries, red cabbage and black rice) and flavan-3-ols (abundant in green tea, cocoa, and apples) selectively stimulate the growth ofand, while often inhibit the proliferation of potential pathogenic bacteria such asandspp. (). Ellagitannins (found in pomegranate, walnuts, strawberries) are not absorbed but are hydrolyzed and metabolized by specific gut bacteria (e.g.,spp.) to form urolithins (). Urolithins themselves have anti-inflammatory and anti-aging properties and can further shape the microbial community toward a more favorable composition. Polyphenols can foster the growth of some beneficial SCFA producers (e.g.,spp.,spp.) and other beneficial symbionts, thereby shifting the compositional landscape of the gut microbiome (;). However, it is important to recognize that most studies demonstrating such compositional shifts have relied on single-timepoint fecal sampling, which cannot capture diurnal oscillatory patterns. Whether these compositional changes translate into restored rhythmicity of microbial metabolic output—i.e., whether phytochemicals reset the amplitude or phase of the microbial clock—remains largely unexamined. Current evidence suggests that polyphenols primarily create a more favorable ecological niche, which may enable the re-establishment of microbial rhythms when combined with appropriate temporal cues such as time-restricted feeding. Direct evidence of phytochemical-mediated rhythmic restoration requires future studies employing time-series metatranscriptomics and controlled feeding paradigms. [Ferrocino et al., 2015] [Bäckhed et al., 2004] [Zhao et al., 2017] [Cardona et al., 2013] [Gerhardt and Mohajeri, 2018] [Li et al., 2020] [Sanna et al., 2019] Akkermansia muciniphila Lactobacillus Bifidobacterium Bifidobacterium Lactobacillus Clostridium perfringens Bacteroides Gordonibacter Faecalibacterium prausnitzii, Roseburia Eubacterium

Whole or minimally processed plant foods (whole grains, legumes, nuts, seeds, and a diverse array of vegetables and fruits) provide synergistic packages of fermentable fibers, polyphenols, vitamins, and minerals. This combination supports a more diverse and functionally resilient microbial network (). Microbial diversity is a key predictor of ecosystem stability and functional redundancy. A diverse microbiome is better equipped to resist stressors like CD. This resilience helps maintain critical functions, such as the rhythmic production of metabolites, even under challenging conditions (;). The fiber provides the bulk substrate for growth, while polyphenols can selectively modulate the sub-populations within that growing community (). [Gilbert et al., 2018] [Le Chatelier et al., 2013] [Sonnenburg and Bäckhed, 2016] [Gupta et al., 2020]

A critical caveat must be acknowledged when interpreting the microecological effects of phytochemicals. Current evidence predominantly demonstrates that these compounds increase the absolute abundance or relative proportion of beneficial taxa (e.g.,) rather than directly restoring their diurnal oscillatory patterns. Whether phytochemicals reset the amplitude or phase of microbial rhythms, or merely provide a constant substrate supply that passively enriches certain populations, remains largely unexplored. Most studies rely on single-timepoint fecal sampling, which obscures dynamic rhythmicity and cannot distinguish between sustained compositional shifts and restored oscillatory function. Thus, while phytochemicals likely create a permissive ecological environment that facilitates rhythmic recovery—particularly when combined with temporal cues such as time-restricted feeding—their ability to directly entrain microbial clocks requires further investigation using time-series metatranscriptomics, longitudinal metabolomics, and controlled feeding paradigms. Akkermansia muciniphila, Bifidobacterium, Lactobacillus

Berberine, an isoquinoline alkaloid derived from medicinal herbs like, has a well-demonstrated ability to inhibit microbial TMA lyases (CutC/D), the enzymes responsible for converting dietary choline and carnitine into trimethylamine (TMA). By reducing TMA production, berberine lowers subsequent host liver-mediated TMAO formation, offering a direct pharmacologic intervention in a CD-exacerbated cardiovascular risk pathway (;,). Dietary Fibers [e.g., inulin, fructo-oligosaccharides (FOS), beta-glucan, arabinoxylan, pectin] are the primary fermentable substrates for SCFA production (). Their consistent and appropriately timed intake ensures a steady supply of precursors (e.g., acetate for butyrogenesis) necessary for rhythmic SCFA synthesis. Different fibers have varying fermentation rates and selectively stimulate different bacterial groups, allowing for nuanced modulation of the SCFA profile (;). Certain polyphenol-derived metabolites (e.g., urolithins, equol) may influence the activity of bacterial enzymes like bile salt hydrolase (BSH), which deconjugates BAs, or 7α-dehydroxylase, which forms secondary BAs. By subtly modulating these activities, phytochemicals can shift the bile acids pool composition toward a more favorable profile, potentially enhancing FXR/TGR5 signaling efficacy (). Coptis chinensis [Shi et al., 2018] [Zhang et al., 2015a] [b] [Sun et al., 2019] [McNabney and Henagan, 2017] [Zhao et al., 2018] [Koppel et al., 2017]

Diets rich in cruciferous vegetables (broccoli, kale, and Brussels sprouts) provide glucosinolates, which are hydrolyzed to bioactive isothiocyanates like sulforaphane. These compounds, or their downstream metabolites, can directly activate the AhR, potentially compensating for deficits in microbially derived AhR ligands caused by dysbiosis (). Furthermore, phytochemicals can steer microbial tryptophan metabolism away from producing potentially harmful metabolites, such as indoxyl sulfate. Instead, they promote the generation of beneficial AhR agonists like indole-3-propionic acid (IPA), which possesses antioxidant and neuroprotective properties and is linked to renal and cardiovascular health benefits (). [Natividad et al., 2018] [Heiss and Olofsson, 2019]

AMPK Pathway Activation: several polyphenols, including resveratrol and quercetin, are potent activators of AMP-activated protein kinase (AMPK), the central cellular energy sensor. AMPK activation promotes catabolic processes (fatty acid oxidation, glucose uptake) and inhibits anabolic ones (lipogenesis, protein synthesis). Intriguingly, AMPK is not just a metabolic sensor but also a circadian regulator. It phosphorylates and destabilizes the core clock protein CRY1, thereby influencing circadian period length () and linking cellular energy status directly to the molecular clockwork. [Lamia et al., 2009]

SIRT1 Pathway Activation: resveratrol is a well-known activator of sirtuin 1 (SIRT1), a NAD+-dependent deacetylase. SIRT1 deacetylates both histones and specific proteins, including core clock components like BMAL1 and PER2. This activity is crucial for maintaining robust circadian amplitude, mitochondrial biogenesis, and metabolic efficiency. Its activation can reinforce circadian rhythmicity, improve insulin sensitivity, and enhance oxidative metabolism (). [Chang and Guarente, 2013]

Nrf2 Pathway Activation: curcumin (from turmeric) and sulforaphane (from broccoli sprouts) are well-characterized natural activators of nuclear factor erythroid 2–related factor 2 (Nrf2), the master transcriptional regulator of the cellular antioxidant and anti-inflammatory response. Oxidative stress is a known disruptor of circadian clocks. By potently inducing a battery of cytoprotective genes (e.g., heme oxygenase-1, NAD(P)H quinone dehydrogenase 1), Nrf2 activation helps maintain cellular redox balance, protects against clock protein damage, and supports metabolic health in the face of inflammatory stressors (,). [Zhang et al., 2015a] [b]

By bolstering these interconnected AMPK-SIRT1-Nrf2 pathways, phytochemicals enhance metabolic flexibility (the ability to switch between fuel sources) and strengthen the host's internal circadian framework. This makes peripheral tissues more resilient and more appropriately responsive to the rhythmic signals from a recovering microbiome (). [Johnston et al., 2016]

Chronic CD and associated dysbiosis are key drivers of increased intestinal permeability (“leaky gut”) (). Curcumin and quercetin possess strong anti-inflammatory (inhibiting NF-κB signaling) and antioxidant properties that have been shown to stabilize tight junction proteins and reduce intestinal permeability in animal models (). By strengthening the gut barrier, these compounds limit the entry of pro-inflammatory bacterial products (e.g., LPS) into circulation. This action alleviates chronic low-grade inflammation (metabolic endotoxemia)—a key driver that connects gut dysbiosis to systemic insulin resistance and metabolic disease (). [Kang et al., 2017] [Cani et al., 2008] [Kashi et al., 2016]

The concept of chrono-nutrition extends to phytochemicals. Administering prebiotic fibers or polyphenol-rich foods during the early active phase/feeding window could maximize SCFA production to coincide with the host's peak insulin sensitivity and heightened energy demand. This aligns microbial metabolic support with host metabolic need (;). Conversely, certain compounds with potent antioxidant or tissue-repair properties (e.g., some polyphenols) might be more beneficial when taken in the evening to support overnight recovery and repair processes, which are under circadian control (). Preliminary evidence supports this principle. For instance, nobiletin—a citrus flavonoid that enhances circadian rhythm by activating specific clock proteins (RORα/γ)—has shown time-dependent effects in mice. When administered in sync with the biological clock, it more effectively improves metabolic health in high-fat diet models (). [Larsen et al., 2010] [Li et al., 2017] [Li et al., 2018] [He et al., 2016]

Combining targeted phytochemical supplementation with TRE represents a powerful, synergistic lifestyle and dietary strategy (). TRE itself is a potent intervention that provides a strong, consistent external cue, powerfully entraining both host peripheral clocks and microbial community rhythms (). Phytochemicals can function within this temporal framework in two key ways. Acting like precision tools, they can selectively promote the growth of beneficial microbes favored by TRE. Concurrently, they provide direct support to host circadian-metabolic pathways during fasting, thereby enhancing autophagy and stress resistance (). Preliminary animal studies suggested that the metabolic benefits of certain polyphenols were indeed more pronounced when their consumption ws contained within a constrained daily feeding window, highlighting the importance of timing (). [Lin et al., 2012] [Panda, 2016] [Liu et al., 2017] [Lozupone et al., 2012]

outlines examples of key phytochemicals, their proposed mechanisms of action on the microbiome and host, and the rationale for their potential optimal timing, drawing upon the evidence reviewed in this section. Table 3

The human gut microbiome exhibits immense variability between individuals. This diversity is shaped by a lifetime of unique exposures—including long-term diet, host genetics, geographic and cultural background, medication history (particularly antibiotics), mode of birth, and the early-life environment (). This results in highly personalized baseline microbial communities and consequently, highly variable responses to both circadian disruptors and phytochemical interventions (;). A universal “one-size-fits-all” prescription for phytochemical type, dose, and timing is unlikely to yield consistent results across a heterogeneous population (). Furthermore, achieving and objectively monitoring long-term adherence to precise dietary timing regimens or specific phytochemical supplementation schedules in free-living individuals presents a major practical and behavioral challenge (). [Meijnikman et al., 2018] [Zeevi et al., 2015] [Zmora et al., 2018] [Miro-Blanch and Yanes, 2019] [Monda et al., 2017]

While rodent FMT studies are powerful for establishing causality in controlled settings, human evidence remains largely correlational. To definitively prove that restoring a specific microbial metabolite rhythm directly improves a clinical metabolic endpoint in humans requires complex, expensive, and logistically demanding longitudinal intervention studies (). These studies need to incorporate high-frequency sampling (multiple samples over 24-h periods) to capture dynamic changes in microbial composition, metabolite fluxes, and host physiology (). There is a pressing need to identify and validate robust, non-invasive biomarkers of a “healthy, rhythmic microbiome” and of circadian alignment (). Such biomarkers (e.g., specific metabolite ratios in urine or blood collected at strategic times, microbial gene expression signatures from serial stool samples) could serve as intermediate endpoints in clinical trials, accelerating the development of chrono-nutritional therapies. [Nagpal et al., 2018] [O'Keefe, 2016] [Parada Venegas et al., 2019]

The bioavailability of many polyphenols is inherently low and highly variable. Key influencing factors include: the food source (whole food vs. extract), culinary processing, and the co-consumption of other foods (e.g., fats which can enhance absorption). Additionally, an individual's gut microbiota composition plays a crucial role, as it transforms many polyphenols into their active forms (). This adds another formidable layer of complexity to standardizing dosing and predicting individual clinical responses. Personalized approaches may need to account for an individual's “metabotype”—their capacity to metabolize specific phytochemicals (;). [Parker et al., 2020] [Patnode et al., 2019] [Petrosino, 2018]

A critical translational challenge arises from the predominant use of nocturnal rodents (mice, rats) in mechanistic studies. Rodents are active during the dark phase and consume the majority of their calories during this period, which is the opposite of diurnal humans. Consequently, concepts such as “time-restricted feeding” or “night-time eating” carry opposite connotations: in rodents, feeding during the light (rest) phase is considered “mistimed,” whereas in humans, feeding during the dark phase is aberrant. Moreover, rodents have significantly higher basal metabolic rates and shorter circadian periods, which may influence the magnitude and kinetics of microbial and metabolic responses to feeding interventions. While TRF has shown robust benefits in both rodents and humans, the direct translation of feeding time windows (e.g., 8- vs. 12-h) and the underlying mechanisms may differ. Future studies should prioritize human trials with rigorous circadian phenotyping and, when using animal models, consider diurnal species (e.g., zebrafish or non-human primates) to better approximate human circadian physiology.

The field must move decisively beyond single-timepoint, static “snapshots” of the microbiome. The future lies in longitudinal “time-series” studies that track the same individuals over time, under different conditions (e.g., during shift work schedules, before and after TRE or phytochemical interventions) (). By integrating multi-omics data—metagenomics (microbial identity), metatranscriptomics (gene activity), metabolomics (from feces, serum, and urine), and host transcriptomics/epigenomics—across multiple 24-h cycles in well-phenotyped cohorts, we can construct detailed, personalized “metabolic rhythm maps.” This systems biology approach can identify which specific nodes in the host-microbe-metabolite network are most disrupted in a given individual or population and predict personalized intervention targets (;). [Jiao et al., 2018] [Thaiss et al., 2014] [Dyar et al., 2018]

The ultimate goal is to tailor dietary and phytochemical interventions to an individual's unique physiological profile. Achieving this requires converging several key data streams (). First, assessing chronotype through questionnaires (e.g., Munich Chronotype Questionnaire) or objective measures like dim-light melatonin onset. Second, performing deep profiling of the gut microbiome and metabolome to understand baseline community structure and metabolic rhythms. Finally, implementing dynamic physiological monitoring using devices like continuous glucose monitors and activity trackers to capture real-time circadian and metabolic data. In addition, machine learning algorithms can then integrate this multimodal data to generate personalized, real-time adaptive recommendations that evolve with changes in an individual's physiology and behavior. These insights would guide personalized recommendations, not only for the optimal timing of meals and specific phytochemical intake, but also for selecting the types of fibers or polyphenols best suited to nourish the individual's unique microbial ecosystem and align with their circadian profile (;;). [Ridaura et al., 2013] [Zeevi et al., 2015] [Bashiardes et al., 2018] [Kolodziejczyk et al., 2019]

Future therapeutic strategies are poised to move beyond conventional approaches in several key directions. Firstly, engineered live biotherapeutic products could be designed as active agents—for instance, bacteria programmed to produce beneficial metabolites like butyrate in response to specific host or dietary cues (). Secondly, the direct use of purified microbial metabolites (e.g., stabilized butyrate derivatives) as “signal restoration therapies” offers a precise way to replenish rhythmic host signals, though it may lack the ecological benefits of modulating the microbiome itself (;). Finally, there is a pressing need for multimodal chrono-therapy trials that systematically test combinations (e.g., time-restricted eating + specific polyphenols + timed light exposure) to reset the clock-microbiome axis and improve metabolic outcomes in targeted populations (). [Park and Im, 2020] [De Vadder et al., 2014] [Plovier et al., 2017] [Sen et al., 2021]